Global News

[ad_1] People gather outside the ArtScience Museum at Marina Bay Sands in Singapore on January 17, 2023. (Photo by Roslan RAHMAN / AFP) (Photo by ROSLAN RAHMAN/AFP via Getty Images) Roslan Rahman | Afp | Getty Images SINGAPORE — Singapore is set to allow non-fully vaccinated travelers to enter the country without a negative pre-departure test from next week, health authorities announced Thursday. The country is set to remove mask-wearing on public transport from Monday, as it seeks to exit the "acute phase" of the pandemic, said the Ministry of Health. The country's Covid task force, created in January 2020, will be deactivated. "Our Covid situation has remained stable over the recent months, despite increased travel over the year and holidays and China's shift from zero Covid," said Singapore's deputy prime minister Lawrence Wong, who is also co-chair of the Covid task force. "Our population has developed a high level of hybrid immunity. The r

[ad_1] Podcaster and comedian Joe Rogan. Vivian Zink | SYFY | NBCUniversal Spotify has signed a new blockbuster deal with polarizing podcaster and comedian Joe Rogan, but this time, his show won't be exclusive to Spotify, the company announced Friday in a news release. The multiyear deal with Rogan, the founder of "The Joe Rogan Experience," is said to be worth about $250 million, according to The Wall Street Journal, which first reported on the deal. The show was the No. 1 podcast in the U.S. for the third quarter of last year, according to Edison Research . Spotify also said it's expanding the partnership to allow the show to be available on other platforms. Shares of the audio streaming giant rose roughly 1.5% Friday. Spotify first brought "The Joe Rogan Experience" to its platform exclusively in 2020 in a deal that was reportedly worth more than $100 million. The talk-show style podcast is known — and often criticized for — its edgy approach and g

[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company's experimental weight loss pill , amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for obesity, including more convenient and potentially cheaper pills.  His remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin. Patients on the pill lost about 13.1% of their weight after 12 weeks, Jørgensen said on CNBC's "Money Movers."  That surpasses the 6% weight loss seen in those who took Wegovy after the same time period. It also adds to the growing enthusiasm around the potential of weight loss pills.  Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on Aug. 10, 2022. Christopher Goodney | Bloomberg | Getty Images Along with conv

[ad_1] Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company's IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company after its solid debut on the public market Thursday.  "In the next quarter and frankly, in the years to come, we are going to continue to do what we do best, which is innovating to find new ways to serve consumers and help them take better care of their health," Mongon told CNBC in an interview shortly after shares of Kenvue started trading on the New York Stock Exchange.   related investing news Shares of the company gained 22% Thursday to close at $26.90 per share. The stock hovered around that level in early trading Friday, giving the company a market value of roughly $50 billion.  Kenvue, spun out of Johnson & Joh

[ad_1] A customer leaves a Bed, Bath and Beyond store on August 31, 2022 in Oakland, California. Justin Sullivan | Getty Images Bed Bath & Beyond wants shareholders to approve a reverse stock split at an upcoming special meeting, as the retailer keeps working to avoid filing for bankruptcy , according to a securities filing late Wednesday.  The retailer's board is calling on shareholders to approve the reverse stock split at the May 9 meeting so it can have enough shares available to raise up to $300 million in equity from a stock offering announced last week.  Bed Bath's fundraising efforts have been hampered by its dwindling stock price, which has been on a precipitous decline and has been trading under $1 for the last few weeks. Shares of Bed Bath were trading around 30 cents Thursday morning, giving the company a market value of about $132 million. The company is concerned that if the plan isn't completed, it likely won't have enough equity to pay its de

[ad_1] There's a global investing opportunity in a corner of health care that is both "significant and underappreciated," according to Barclays. The segment is clinical nutrition, which the bank defined as an area focused on patients who need specific supplemental nutrition because of chronic health care conditions or because they are unable to eat. Barclays pointed to several growth drivers: "Rising chronic conditions, ageing populations and continued pressure on healthcare spending should continue to support the growth of this industry." "Clinical nutrition provides supplemental nutrition for those who are malnourished and is a significant and underappreciated opportunity worth c.$19bn today, driven by strong underlying themes such as ageing population, malnutrition and an increasing focus on self-care," the bank said in an April 12 note. It expects the market will grow to $28 billion by 2030, with China's share of the market rising from 20%

[ad_1] AT&T Inc : "It's not as bad as it used to be." Plug Power Inc : "[CEO] Andy Marsh has promised us profitably for a very long time. ... My bountiful patience is beginning to get tried." Devon Energy Corp : "Keep buying." Disclaimer: Cramer's Charitable Trust owns shares of Devon Energy. Jim Cramer's Guide to Investing Click here to download   Jim Cramer's Guide to Investing  at no cost to help you build long-term wealth and invest smarter. [ad_2] Source link https://worldnews2023.com/business/cramers-lightning-round-i-like-juniper-networks/?feed_id=293300&_unique_id=65fe472c5df52

[ad_1] NYT Columnist Andrew Ross Sorkin and C.E.O. of The Walt Disney Company Bob Iger speak during the New York Times annual DealBook summit on November 29, 2023 in New York City.  Michael M. Santiago | Getty Images It's the most wonderful time of the year! It's the third annual anonymous media and entertainment executive predictions list! In honor of the 12 days of Christmas, I asked 12 past and current executives at the world's biggest media and entertainment companies for one industry-shaking prediction for 2024. And then I asked one more because this is the holiday season, and I was feeling generous. A baker's dozen! Actually, I asked a few more, but some overlapped. Quite a few of last year's predictions were accurate . Disney Chief Executive Bob Iger did extend his contract . Christine McCarthy stepped down as Disney's chief financial officer. Paramount Global hasn't sold, but controlling shareholder Shari Redstone is now in talks to sell Natio

[ad_1] Lana Payne celebrates on stage as Unifor, Canada's largest private-sector union, announce Payne as their new president to replace outgoing leader Jerry Dias in Toronto, Ontario, Canada, Aug. 10, 2022. Cole Burston | Reuters DETROIT — Canadian union Unifor and Stellantis have reached a tentative agreement early Monday morning, ending a brief strike that began after a deal wasn't reached by 11:59 p.m. Sunday. The Canadian work stoppage involved more than 8,200 autoworkers at several facilities in the Canadian province of Ontario, including two large assembly plants that produce the Chrysler 300 sedan and Pacifica minivan and the Dodge Challenger and Charger muscle cars. The strike and tentative deal, which must still be ratified by union members, occurred two days after Stellantis reached a tentative deal for about 43,000 U.S. autoworkers with the United Auto Workers union after roughly six weeks of targeted strikes that began Sept. 15. Details of the tentative ag

[ad_1] Akio Toyoda, president and CEO of Toyota Motor Corp. Kiyoshi Ota | Bloomberg | Getty Images DETROIT – Toyota Motor stock sealed its best week since 2009 on Friday, as the automaker laid out a robust plan for future all-electric vehicles and company scion Akio Toyoda became leader of the Japanese company's board. Shares of Toyota on the New York Stock Exchange closed Friday at $164.35 per share, down 2.3% for the day but still up 10.6% on the week. That 5-day gain is the stock's best week since April 2009 when shares increased 14.5%. Such a rally is not typical for the stock. It's only the third double-digit weekly gain in more than two decades for the relatively well-performing but mundane stock. Shares of the company are up 20% so far in 2023. The positive uptick this year comes as recent supply chain problems ease for the automotive industry, including Toyota, and after Toyoda, grandson of the company's founder, announced plans to transition from CEO to

[ad_1] MUMBAI: The street failed to take comfort from Paytm management's assurance to investors that the company would disassociate from Paytm Payments Bank (PPBL) and partner with other banks following the Reserve Bank of India’s (RBI) move to severely restrict operations of PPBL. For the second straight day, the stock price of One 97 Communications (OCL) which owns Paytm slid 20% and hit lower circuit of Rs487 on Friday, down 77% from IPO price.The stock got hammered even after founder and CEO Vijay Shekhar Sharma assured consumers that the Paytm app will continue working beyond February 29. Earlier this week, RBI barred PPBL from adding funds to any customer accounts, ending the utility of most of its services with effect from March 1. Rivals, meanwhile, seem to be eating into Paytm’s market share. “We are seeing a surge in inbound requests from merchants for QRs and Smart speakers and we are making sure we meet that demand,” a PhonePe spokesperson said in response to q

[ad_1] Federal Reserve Chairman Jerome Powell testifies during the Senate Banking, Housing, and Urban Affairs Committee hearing titled The Semiannual Monetary Policy Report to the Congress, in Hart Building on Tuesday, March 7, 2023. Tom Williams | Cq-roll Call, Inc. | Getty Images When the Federal Reserve starts to raise interest rates, it generally keeps doing so until something breaks, or so goes the collective Wall Street wisdom. So with the second- and third-largest bank failures ever in the books happening just over the past few days, and worries of more to come, that would seem to qualify as significant breakage and reason for the central bank to back off. related investing news Not so fast. Even with the failure over the past several days of Silicon Valley Bank and Signature Bank that forced regulators to spring into action , markets still expect the Fed to keep up its inflation-fighting efforts. Suring bond yields played into the demise in particular of SVB as the bank fa

[ad_1] A variety of generic pills and capsules.  Nenov | Moment | Getty Images The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs, which account for the majority of Americans' prescriptions. The move follows an unprecedented shortfall of crucial medicine ranging from injectable cancer therapies to generics, or cheaper versions of brand-name medicines, over the last year, which has forced hospitals and patients to ration drugs. Problems from manufacturing quality control to demand surges can drive supply issues. But the Biden administration is zeroing in on other players in the drug supply chain to uncover the "root causes and potential solutions" to ongoing shortages.  In a joint request for information, the FTC and the Department of Health and Human Services are seeking public comment on the contracting practices, m

[ad_1] Former U.S. President Donald Trump departs for his second civil trial after E. Jean Carroll accused Trump of raping her decades ago, outside a Trump Tower in the Manhattan borough of New York City, U.S., January 26, 2024.  Eduardo Munoz | Reuters A federal jury on Friday said that Donald Trump must pay E. Jean Carroll $83.3 million in compensatory and punitive damages for defaming her in statements he made as president when the writer said he had raped her in the 1990s. The massive verdict came less than three hours after the nine-member jury began deliberating in U.S. District Court in Manhattan following closing arguments in the trial. Trump was not in court for the verdict's reading at 4:40 p.m. ET. Judge Lewis Kaplan told jurors before their deliberations that they had to accept as facts that Trump "sexually assaulted" Carroll in the mid-1990s and defamed the writer in statements he made as president in 2019. "What remains for you to decide," Kap